Human milk oligosaccharides are difficult and expensive to produce at scale for infant and adult nutrition.
R&D Focus
Biosynthetic human milk oligosaccharides
Innovative Solution
Synaura manufactures, supplies, and develops human milk oligosaccharides (HMO) for breastfed infants. The company specializes in biosynthesis technology and provides baby formula that has the same nutritional value as breast milk, allowing customers to use HMO products.
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
13.85M
Last Funding Date
22-10-2024
Startup Stage
Early Stage
Lead Investors
China Mengniu Dairy, Kweichow Moutai, CICC Qide, Zhongjin Qide
About
Synaura manufactures, supplies, and develops human milk oligosaccharides (HMO) for breastfed infants. The company specializes in biosynthesis technology and provides baby formula that has the same nutritional value as breast milk, allowing customers to use HMO products.
Products
Product
Human milk oligosaccharide ingredients produced through biosynthesis.
Demo Product or Complete Product?
Development-stage technology or ingredient platform; commercialization or clinical development is ongoing.
Something missing or incorrect on this page? Help us enrich this information
